BMI

Factors that increase risk for deep or nonpalpable implant, 12-hour vs. 24-hour mifepristone-misoprostol interval, and two studies reinforcing the safety and efficacy of no-test medication abortion.

OTC birth control pill self-selection, adherence, and interest; IUD expulsion risks; and IUD and implant side effects.

Abortion information on TikTok, doxy-PEP effectiveness in cis-gendered women; new data on UPA-EC and implant insertion; and a survey of pain with IUD insertion.

Taking a patient-centered approach to talking about body weight and birth control effectiveness.

Perceived pain and sedation dosing during abortion procedures by demographics, PAPP-A as a novel screening for gestational age before medication abortion, patient experiences with progestin-only pills and attitudes towards OTC access.

Dispelling misinformation about EC with your patients.

Health care provider misconceptions about birth control as an abortifacient, a comprehension study of an over-the-counter combination birth control pill label, an updated Consensus from ACOG on menstrual suppression, and the effect of state-level abortion restrictions on early pregnancy loss management.

ICYMI, here are the 10 best new things to happen to birth control in the last 10 years.